Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk
Open Access
- 16 December 2012
- journal article
- research article
- Published by Springer Nature in Current Nutrition Reports
- Vol. 2 (1) , 1-9
Abstract
Obesity and related metabolic alterations have been implicated to play a role in colorectal cancer risk. The metabolic syndrome, as assessed according to current international definitions by the key components, abdominal obesity, dyslipidemia, elevated blood pressure, and abnormal glucose metabolism, is associated with colorectal cancer. Recent studies suggest that abdominal obesity and abnormal glucose metabolism may primarily account for this association. Visceral adipose tissue is physiologically more active than subcutaneous adipose tissue and generates hormones and cytokines with inflammatory, metabolic, and direct carcinogenic potential, which may directly or indirectly increase colorectal cancer risk. Current evidence suggests that obesity acts as a risk factor for colorectal cancer by several mechanisms, including chronic low-grade inflammation, hyperinsulinemia, as well as alterations in insulin-like growth factor and adipokine concentrations. Metabolic biomarkers reflecting these processes may not only provide clues for etiological understanding of colorectal carcinogenesis but also might be an alternative way to define an “obesity phenotype” that is relevant for colorectal cancer development.Keywords
This publication has 98 references indexed in Scilit:
- Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition StudyCarcinogenesis, 2012
- A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal womenBritish Journal of Cancer, 2011
- Adiponectin gene and risk of colorectal cancerBritish Journal of Cancer, 2011
- Inflammatory Markers Are Associated With Risk of Colorectal Cancer and Chemopreventive Response to Anti-Inflammatory DrugsGastroenterology, 2011
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Genetic variation in C‐reactive protein in relation to colon and rectal cancer risk and survivalInternational Journal of Cancer, 2010
- Postmenopausal Levels of Endogenous Sex Hormones and Risk of Colorectal CancerCancer Epidemiology, Biomarkers & Prevention, 2009
- Insulin, Insulin-like Growth Factor-I, Endogenous Estradiol, and Risk of Colorectal Cancer in Postmenopausal WomenCancer Research, 2008
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2New England Journal of Medicine, 2007
- Inflammation and cancerNature, 2002